PTC Therapeutics Inc - Company Profile

Powered by

All the data and insights you need on PTC Therapeutics Inc in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date PTC Therapeutics Inc Strategy Report

  • Understand PTC Therapeutics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

PTC Therapeutics Inc: Patents

Select Item

Related keylists

View up-to-date information on PTC Therapeutics Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP4059922A1 Application POLYMORPHE UND AMORPHE FORMEN VON (R) (-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTTERSÄUREAMID A61K31/122; A61K31/164; A61P13/02; A61P13/12; A61P21/00; A61P21/02; A61P21/04; A61P25/00; A61P25/02; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P27/02; A61P27/06; A61P27/16; A61P3/00; A61P3/02; A61P3/10; A61P35/00; A61P39/02; A61P43/00; A61P7/00; A61P7/06; A61P9/00; A61P9/10; C07B2200/13; C07B57/00; C07C215/08; C07C215/28; C07C215/30; C07C231/12; C07C235/78; C07C2601/16 September 21, 2022
DK3889142T3 Application 1,2,4-OXADIAZOLBENZOESYREFORBINDELSER OG DERES ANVENDELSE TIL NONSENSE-SUPPRESSION OG BEHANDLING AF SYGDOM A61K31/4245; A61K31/4439; A61K31/454; A61K31/4545; A61K31/5377; A61K31/655; A61K45/06; A61K9/0053; A61K9/12; A61K9/48; A61P27/02; C07D271/06; C07D271/12; C07D285/14; C07D413/02; C07D413/04; C07D413/10 September 12, 2022
CA2842486C Grant METHODS FOR OXIDATION OF ALPHA TOCOTRIENOL IN THE PRESENCE OF NON-ALPHA TOCOTRIENOLS A61P21/00; A61P27/02; A61P43/00; C07C2601/16; C07C403/08; C07C46/06; C07D311/72 September 06, 2022
AU2019294482B2 Grant Heteroaryl compounds for treating Huntington's disease A61K31/454; A61K31/5025; A61P25/00; A61P25/14; A61P25/28; C07D417/14; C07D471/04; C07D487/04; C07D498/04; C07D513/04; C07D519/00 September 01, 2022
US20220273661A1 Application USE OF SEPIAPTERIN AND METABOLITES THEREOF TO TREAT RADIATION EXPOSURE A61K31/519; A61P39/00 September 01, 2022
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Find out more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward